Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 30;23(1):623.
doi: 10.1186/s12884-023-05926-6.

Serologic evolution and follow-up to IgG antibodies of infants born to mothers with gestational COVID

Sara Vigil-Vázquez  1 , Ángela Manzanares  2   3 , Alicia Hernanz-Lobo  2   3   4 , Itziar Carrasco-García  2   3   4 , Clara Zamora Del Pozo  5 , Alba Pérez-Pérez  6 , Elena María Rincón-López  2   3   4 , Begoña Santiago-García  2   3   4 , María Del Pilar Pintado-Recarte  5 , Roberto Alonso-Fernández  7   8 , Manuel Sánchez-Luna  6   8 , María Luisa Navarro-Gómez  2   3   4   8
Affiliations

Serologic evolution and follow-up to IgG antibodies of infants born to mothers with gestational COVID

Sara Vigil-Vázquez et al. BMC Pregnancy Childbirth. .

Abstract

Background: It is known that SARS-CoV-2 antibodies from pregnant women with SARS-CoV-2 infection during pregnancy cross the placenta but the duration and the protective effect of these antibodies in infants is scarce.

Methods: This prospective study included mothers with SARS-COV-2 infection during pregnancy and their infants from April 2020 to March 2021. IgG antibodies to SARS-CoV-2 spike protein were performed on women and infants at birth and at two and six months during follow-up. Anthropometrical measures and physical and neurological examinations and a clinical history of symptoms and COVID-19 diagnosis were collected. Simple linear regression was performed to compare categorical and continuous variables. To compare the mother's and infant's antibody titers evolution, a mixed linear regression model was used. A predictive model of newborn antibody titers at birth has been established by means of simple stepwise linear regression.

Results: 51 mother-infant couples were included. 45 (90%) of the mothers and 44 (86.3%) of the newborns had a positive serology al birth. These antibodies were progressively decreasing and were positive in 34 (66.7%) and 7 (13.7%) of infants at 2 and 6 months, respectively. IgG titers of newborns at birth were related to mothers' titers, with a positive moderate correlation (Pearson's correlation coefficient: 0.82, p < 0,001). Fetal/maternal antibodies placental transference rate was 1.3 (IQR: 0.7-2.2). The maternal IgG titers at delivery and the type of maternal infection (acute, recent, or past infection) was significantly related with infants' antibody titers at birth. No other epidemiological or clinical factors were related to antibodies titers. Neurodevelopment, psychomotor development, and growth were normal in 94.2% of infants in the third follow-up visit. No infants had a COVID-19 diagnosis during the follow-up period.

Conclusions: Transplacental transfer of maternal antibodies is high in newborns from mothers with recent or past infection at delivery, but these antibodies decrease after the first months of life. Infant's IgG titers were related to maternal IgG titers at delivery. Further studies are needed to learn about the protective role of maternal antibodies in infants.

Keywords: Antibodies titers; Antibodies transplacental transfer; Gestational COVID; Neonatal SARS-COV-2 infection; Serological test.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Box-and-whisker plot for log10 IgG values between mothers and newborns
Fig. 2
Fig. 2
Scatter plots and correlation lines. (A) Infants IgG antibodies levels at birth according to maternal IgG antibodies levels. (B) Placental transfer ratio according to maternal IgG antibody levels
See this image and copyright information in PMC

References

    1. WHO Coronavirus (COVID-19.) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/. Accessed 19 Dec 2021.
    1. Albrecht M, Pagenkemper M, Wiessner C, Spohn M, Lütgehetmann M, Jacobsen H, et al. Infant immunity against viral infections is advanced by the placenta-dependent vertical transfer of maternal antibodies. Vaccine. 2021 doi: 10.1016/j.vaccine.2020.12.049. - DOI - PubMed
    1. Glezen WP. Effect of maternal antibodies on the infant immune response. Vaccine. 2003;21:3389–92. doi: 10.1016/S0264-410X(03)00339-6. - DOI - PubMed
    1. Flannery DD, Gouma S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Woodford EC, et al. Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios. JAMA Pediatr. 2021;175:594–600. doi: 10.1001/jamapediatrics.2021.0038. - DOI - PMC - PubMed
    1. Joseph NT, Dude CM, Verkerke HP, Irby LS, Dunlop AL, Patel RM, et al. Maternal antibody response, neutralizing potency, and placental antibody transfer after severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Obstet Gynecol. 2021;138:189–97. doi: 10.1097/AOG.0000000000004440. - DOI - PMC - PubMed